Lupin partners with Sandoz to commercialize Ranibizumab biosimilar in multiple global markets
Lupin Limited announced on August 12 that it has entered into a licensing and commercialization agreement with Switzerland-based Sandoz Group AG for its biosimilar Ranibizumab. The deal covers multiple regions, including the European Union (excluding Germany), Switzerland, Norway, Australia, Hong Kong, Vietnam, and Malaysia.
Under the agreement, Lupin will handle manufacturing and regulatory submissions, while Sandoz will oversee commercialization. Sandoz will hold exclusive marketing rights in most designated markets, except for France, Australia, Vietnam, and Malaysia, where rights will be semi-exclusive. In a separate arrangement, Sandoz will acquire sole commercialization rights for Canada.
Ranibizumab is a monoclonal antibody fragment that binds to and inhibits VEGF-A, used in treating conditions such as Neovascular (Wet) Age-Related Macular Degeneration, Diabetic Macular Edema, Proliferative Diabetic Retinopathy, and other retinal diseases.
Thierry Volle, President EMEA and Emerging Markets at Lupin, said the partnership aligns with both companies' vision to expand global access to advanced biologic therapies and improve outcomes for underserved patients.
Lupin, a global pharmaceutical leader headquartered in Mumbai, has a presence in over 100 markets, with 15 manufacturing sites and seven research centers worldwide.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Swiss gold industry warns against Swatch boss's US gold tax proposal
ZURICH (Reuters) -Switzerland's gold industry on Thursday voiced scepticism about a proposal by the boss of watchmaker Swatch to introduce a levy on gold exports to the United States in retaliation for U.S. tariffs on Switzerland. U.S. President Donald Trump last week imposed tariffs of 39% on imported Swiss goods, causing shock and dismay in the Alpine republic, a major refining and transit hub for gold. The U.S. Customs and Border Protection afterwards said Washington might put tariffs on the most widely-traded gold bullion bars in the United States. However, Trump said on Monday that gold would not face tariffs. Swatch CEO Nick Hayek told Swiss newspaper Blick that Trump's announcement indicated that tariffs on gold would be painful for the U.S. president. "Now is the time to go on the offensive. Switzerland should order a 39% export tax on gold bars for the United States," Hayek told the paper. "That's where we have to get at him. That's his Achilles' heel." The Swiss Association of Manufacturers and Traders in Precious Metals (ASFCMP) said that while ideas to better balance bilateral trade were welcome, careful consideration needed to be given to Switzerland's longer-term interests. "An export tax on Swiss gold destined for the USA would not only harm Switzerland economically, but also damage the reputation of a country that has consistently promoted and defended free trade," ASFCMP President Christoph Wild said. The Swiss Economy Ministry declined to comment on the proposal, but said the support of business representatives was in general welcome and helped underscore the close economic ties between the U.S. and Switzerland. Trump justified his 39% tariff by pointing to Switzerland's sizeable trade surplus with the United States. Part of that is due to gold exports. Hayek said that even if a gold levy failed to move Trump, it would cut the U.S. trade deficit with Switzerland. "If Trump doesn't give in to our pressure, we'll at least improve the trade balance with the U.S. if the Americans no longer import gold bars via Switzerland," he told Blick. Switzerland is continuing to hold talks with U.S. officials aimed at lowering the U.S. tariffs. (Writing by Dave GrahamEditing by Mark Potter)
San Francisco Chronicle
15 minutes ago
- San Francisco Chronicle
Zeekr: Q2 Earnings Snapshot
NINGBO, China (AP) — NINGBO, China (AP) — Zeekr Intelligent Technology Holding Ltd. (ZK) on Thursday reported a loss of $55 million in its second quarter. The Ningbo, China-based company said it had a loss of 21 cents per share. Losses, adjusted for stock option expense, came to 20 cents per share. The electric vehicle maker posted revenue of $3.83 billion in the period.
Business Upturn
16 minutes ago
- Business Upturn
S&P Global says US tariffs will not derail India's long-term growth prospects
By Aditya Bhagchandani Published on August 14, 2025, 14:51 IST S&P Global Ratings has stated that even if the United States imposes a 50% tariff on Indian imports, the impact on the country's long-term growth prospects will be minimal. The agency noted that while the US remains India's largest trading partner, the scale of exposure is relatively small in GDP terms. According to S&P, India's exports to the US account for around 2% of GDP. Once sectoral exemptions—particularly for pharmaceuticals and consumer electronics—are factored in, the share of exports that could be subjected to tariffs drops to 1.2% of GDP. This, the agency said, could lead to a short-term hit to growth but would not have a lasting effect on the country's economic trajectory. S&P further highlighted that despite potential revenue losses and slower gains from trade, India is on track to meet its FY26 fiscal deficit target. The government's commitment to fiscal consolidation, coupled with robust domestic demand and infrastructure spending, is expected to help offset any external shocks. The agency maintained its view that India's economic fundamentals—driven by strong investment momentum, policy stability, and resilient domestic consumption—remain intact, ensuring that the country's growth outlook stays positive in the medium to long term. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
